Full history for every metric is available with a Kvantra account
Stock profile
Dyax Corp. (DYAX)
Current price
38.41 USD+0.26%
Last close 21 Jan 2016Benchmarks
Key financial summary
Financials in USD| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 22 | 51 | 49 | 55 | 54 | 82 | 98 |
| Operating profit | $m | -1 | -19 | |||||
| Net profit | $m | -62 | -25 | -35 | -29 | -28 | -12 | -30 |
| EPS reported | $ | -0.11 | -0.21 | |||||
| Operating cashflow per share | $ | - | -0.06 | |||||
| Capex per share | $ | - | 0.00 | |||||
| FCF per share | $ | - | -0.07 | |||||
| Free cash flow | $m | -9 | -26 | |||||
| Net debt | $m | -102 | -284 | |||||
| Book value equity | $m | 106 | 314 | |||||
| Book value per share | $ | 0.97 | 2.20 | |||||
| Number of shares | m | 108.54 | 142.81 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 14.42 | 49.68 | |||||
| P/S LTM | x | 18.67 | 0.00 | |||||
| P/FCF LTM | x | -166.53 | 0.00 | |||||
| EV/EBITDA LTM | x | 2,909.96 | 114.97 | |||||
| EV/Sales LTM | x | - | 0.77 | |||||
| Earnings Yield LTM | % | - | -0.23% | |||||
| FCF Yield | % | -0.60% | - | |||||
| Quality | ||||||||
| ROE | % | - | -17.98% | |||||
| ROIC | % | - | -0.63% | |||||
| Operating margin | % | - | -1.51% | |||||
| Gross margin | % | - | 94.24% | |||||
| FCF/Sales | % | - | -11.21% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +51.55% | +34.45% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | -0.11 | -1.05 | |||||
| Net Debt/EBITDA | x | - | 114.97 | |||||
| EBIT/Net interest | x | - | -0.11 | |||||
| Net debt/market cap | % | -6.72% | - | |||||
| Net debt/Equity | x | -0.97 | -0.90 | |||||
| Gross debt/equity | x | 0.78 | 0.08 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
DY
Dyax Corp. (DYAX)
DYAX · NASDAQ · Healthcare
38.41 USD+0.26%
Benchmarks
Financialsin USD
20132014TTM
Total revenue $m548298
Operating profit $m-1-19
Net profit $m-28-12-30
EPS reported $-0.11-0.21
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free